
TY  - JOUR
AU  - Iba, T.
AU  - Levy, J. H.
TI  - Derangement of the endothelial glycocalyx in sepsis
JO  - Journal of Thrombosis and Haemostasis
JA  - J Thromb Haemost
VL  - 17
IS  - 2
SN  - 1538-7933
UR  - https://doi.org/10.1111/jth.14371
DO  - doi:10.1111/jth.14371
SP  - 283
EP  - 294
KW  - endothelial surface layer
KW  - glycocalyx
KW  - microcirculation
KW  - organ dysfunction
KW  - sepsis
PY  - 2019
AB  - Summary The vascular endothelial surface is coated by the glycocalyx, a ubiquitous gel-like layer composed of a membrane-binding domain that contains proteoglycans, glycosaminoglycan side-chains, and plasma proteins such as albumin and antithrombin. The endothelial glycocalyx plays a critical role in maintaining vascular homeostasis. However, this component is highly vulnerable to damage and is also difficult to examine. Recent advances in analytical techniques have enabled biochemical, visual and computational investigation of this vascular component. The glycocalyx modulates leukocyte?endothelial interactions, thrombus formation and other processes that lead to microcirculatory dysfunction and critical organ injury in sepsis. It also acts as a regulator of vascular permeability and contains mechanosensors as well as receptors for growth factors and anticoagulants. During the initial onset of sepsis, the glycocalyx is damaged and circulating levels of glycocalyx components, including syndecans, heparan sulfate and hyaluronic acid, can be measured and are reportedly useful as biomarkers for sepsis. Also, a new methodology using side-stream dark-field imaging is now clinically available for assessing the glycocalyx. Multiple factors including hypervolemia and hyperglycemia are toxic to the glycocalyx, and several agents have been proposed as therapeutic modalities, although no single treatment has been proven to be clinically effective. In this article, we review the derangement of the glycocalyx in sepsis. Despite the accumulated knowledge regarding the important roles of the glycocalyx, the relationship between derangement of the endothelial glycocalyx and severity of sepsis or disseminated intravascular coagulation has not been adequately elucidated and further work is needed.
ER  - 

TY  - JOUR
AU  - Butler-Manuel, Simon A.
AU  - Gould, Deborah A.
AU  - Thomas, Stephen M.
AU  - Carter, Paul G.
AU  - Barton, Desmond P. J.
TI  - Thromboembolic disease as a presentation of-gynaecological malignancy
JO  - BJOG: An International Journal of Obstetrics & Gynaecology
VL  - 104
IS  - 12
SN  - 1470-0328
UR  - https://doi.org/10.1111/j.1471-0528.1997.tb11014.x
DO  - doi:10.1111/j.1471-0528.1997.tb11014.x
SP  - 1413
EP  - 1415
PY  - 1997
ER  - 

TY  - JOUR
AU  - Montes, Ramón
AU  - Guruceaga, Elisabet
AU  - González-Porras, José R.
AU  - Reverter, Joan C.
AU  - Marco, Pascual
AU  - Pina, Elena
AU  - Páramo, José A.
AU  - Hermida, José
AU  - Lecumberri, Ramón
AU  - Grupo de Trabajo de Patología Trombótica de la Sociedad Española de Trombosis y Hemostasia (SETH)
TI  - Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study
JO  - European Journal of Haematology
JA  - Eur J Haematol
VL  - 97
IS  - 2
SN  - 0902-4441
UR  - https://doi.org/10.1111/ejh.12692
DO  - doi:10.1111/ejh.12692
SP  - 128
EP  - 136
KW  - deep venous thrombosis
KW  - recurrence
KW  - gene expression profiling
KW  - ACSF2
PY  - 2016
AB  - Abstract Objective The aim of this study was to assess differences in the gene expression profile of peripheral blood cells between patients with early recurrent thrombosis vs. patients without recurrent events after withdrawal of anticoagulant therapy for a first episode of unprovoked deep vein thrombosis (uDVT), to identify novel predictors of recurrence. Methods In the discovery population (N = 32), a microarray RNA assay followed by RT-PCR confirmation were performed. In the validation population (N = 44) a multiple RT-PCR-based strategy was applied to assess genes differentially expressed in the discovery population. Results The sex-adjusted Linear Model for Microarray Data analysis showed 102 genes differentially expressed (P < 0.01) in the discovery population. Nineteen of them underwent further confirmation in the validation population. The gene encoding for Acyl-CoA Synthetase Family Member 2 (ACSF2) was underexpressed in recurrent DVT patients in both, the discovery (P = 0.007) and validation populations (P = 0.004). In the receiver operator characteristic (ROC) analysis, the areas under the curve of ACSF2 expression were 0.77 and 0.80, respectively. Conclusions For the first time an association between ACSF2 expression and the risk of recurrent DVT is suggested. Should this association be confirmed in larger prospective studies, ACSF2 could become useful for the selection of patients requiring extended anticoagulant therapy.
ER  - 

TY  - JOUR
TI  - THSNA 2018 Summit Abstract Proceedings
JO  - American Journal of Hematology
JA  - Am J Hematol
VL  - 93
IS  - 9
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.25268
DO  - doi:10.1002/ajh.25268
SP  - E253
EP  - E328
PY  - 2018
ER  - 

TY  - JOUR
TI  - Society for the Advancement of Blood Management Poster Abstracts from the SABM 2006 Annual Meeting
JO  - Transfusion
VL  - 47
IS  - 2
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.2007.01123.x
DO  - doi:10.1111/j.1537-2995.2007.01123.x
SP  - 1A
EP  - 9A
PY  - 2007
ER  - 

TY  - JOUR
TI  - Author index
JO  - Cephalalgia
VL  - 14
IS  - 6
SN  - 0333-1024
UR  - https://doi.org/10.1046/j.1468-2982.1994.1406i.x
DO  - doi:10.1046/j.1468-2982.1994.1406i.x
SP  - i
EP  - x
PY  - 1994
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - International Journal of Laboratory Hematology
JA  - Int. Jnl. Lab. Hem.
VL  - 38
IS  - S2
SN  - 1751-5521
UR  - https://doi.org/10.1111/ijlh.12567
DO  - doi:10.1111/ijlh.12567
SP  - 1
EP  - 119
PY  - 2016
ER  - 

TY  - JOUR
TI  - Monday 4th April 2011 Free Communications: Haemostasis and Thrombosis
JO  - British Journal of Haematology
VL  - 153
IS  - s1
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.2011.08609.x
DO  - doi:10.1111/j.1365-2141.2011.08609.x
SP  - 1
EP  - 88
PY  - 2011
ER  - 

TY  - JOUR
TI  - Ards
JO  - Acta Anaesthesiologica Scandinavica
VL  - 40
IS  - s109
SN  - 0001-5172
UR  - https://doi.org/10.1111/j.1399-6576.1996.tb04577.x
DO  - doi:10.1111/j.1399-6576.1996.tb04577.x
SP  - 61
EP  - 74
PY  - 1996
ER  - 

TY  - JOUR
TI  - ASBMR 26th Annual Meeting M001–M585
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 19
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650191306
DO  - doi:10.1002/jbmr.5650191306
SP  - S343
EP  - S484
PY  - 2004
ER  - 

TY  - JOUR
TI  - Administrative Abstracts
JO  - Transfusion
JA  - Transfusion
VL  - 53
IS  - S2
SN  - 0041-1132
UR  - https://doi.org/10.1111/trf.12401_2
DO  - doi:10.1111/trf.12401_2
SP  - 219
EP  - 278A
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster abstracts
JO  - International Journal of Laboratory Hematology
VL  - 33
IS  - s1
SN  - 1751-5521
UR  - https://doi.org/10.1111/j.1751-553X.2011.01329.x
DO  - doi:10.1111/j.1751-553X.2011.01329.x
SP  - 53
EP  - 136
PY  - 2011
ER  - 

TY  - JOUR
TI  - Scientific Section
JO  - Transfusion
VL  - 39
IS  - S10
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.1537-2995.1999.tb05925.x
DO  - doi:10.1111/j.1537-2995.1999.tb05925.x
SP  - 1S
EP  - 123S
PY  - 1999
ER  - 

TY  - JOUR
TI  - Free Communication: Presidential Selection
JO  - British Journal of Haematology
VL  - 149
IS  - s1
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.2010.08116.x
DO  - doi:10.1111/j.1365-2141.2010.08116.x
SP  - 1
EP  - 26
PY  - 2010
ER  - 

TY  - JOUR
AU  - Boire, Timothy C.
AU  - Balikov, Daniel A.
AU  - Lee, Yunki
AU  - Guth, Christy M.
AU  - Cheung-Flynn, Joyce
AU  - Sung, Hak-Joon
TI  - Biomaterial-Based Approaches to Address Vein Graft and Hemodialysis Access Failures
JO  - Macromolecular Rapid Communications
JA  - Macromol. Rapid Commun.
VL  - 37
IS  - 23
SN  - 1022-1336
UR  - https://doi.org/10.1002/marc.201600412
DO  - doi:10.1002/marc.201600412
SP  - 1860
EP  - 1880
KW  - biomaterials
KW  - biocompatibility
KW  - biodegradability
KW  - external stents
KW  - mechanical properties
PY  - 2016
AB  - Veins used as grafts in heart bypass or as access points in hemodialysis exhibit high failure rates, thereby causing significant morbidity and mortality for patients. Interventional or revisional surgeries required to correct these failures have been met with limited success and exorbitant costs, particularly for the US Centers for Medicare & Medicaid Services. Vein stenosis or occlusion leading to failure is primarily the result of neointimal hyperplasia. Systemic therapies have achieved little long-term success, indicating the need for more localized, sustained, biomaterial-based solutions. Numerous studies have demonstrated the ability of external stents to reduce neointimal hyperplasia. However, successful results from animal models have failed to translate to the clinic thus far, and no external stent is currently approved for use in the US to prevent vein graft or hemodialysis access failures. This review discusses current progress in the field, design considerations, and future perspectives for biomaterial-based external stents. More comparative studies iteratively modulating biomaterial and biomaterial-drug approaches are critical in addressing mechanistic knowledge gaps associated with external stent application to the arteriovenous environment. Addressing these gaps will ultimately lead to more viable solutions that prevent vein graft and hemodialysis access failures.
ER  - 

TY  - JOUR
TI  - Abstracts of papers presented at the 27th Annual Scientific Meeting of the Australasian Society of Blood Transfusion, Hobart, Australia, 19–22 September 1993
JO  - Transfusion Medicine
VL  - 4
IS  - 1
SN  - 0958-7578
UR  - https://doi.org/10.1111/j.1365-3148.1994.tb00246.x
DO  - doi:10.1111/j.1365-3148.1994.tb00246.x
SP  - 71
EP  - 89
PY  - 1994
ER  - 

TY  - JOUR
TI  - Publication Only
JO  - Journal of Thrombosis and Haemostasis
VL  - 9
IS  - s2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2011.04380_6.x
DO  - doi:10.1111/j.1538-7836.2011.04380_6.x
SP  - 963
EP  - 970
PY  - 2011
ER  - 

TY  - JOUR
AU  - Nord, Carl Erik
AU  - Heimdahl, Anders
TI  - Cardiovascular infections: bacterial endocarditis of oral origin. Pathogenesis and prophylaxis
JO  - Journal of Clinical Periodontology
VL  - 17
IS  - s1
SN  - 0303-6979
UR  - https://doi.org/10.1111/j.1365-2710.1992.tb01221.x
DO  - doi:10.1111/j.1365-2710.1992.tb01221.x
SP  - 494
EP  - 496
KW  - bacterial endocarditis
KW  - oral origin
KW  - pathogenesis
KW  - prophylaxis
PY  - 1990
AB  - Abstract. The diagnosis infective endocarditis describes infection of the endocardial surface of the heart and indicates the presence of micro-organisms in the lesion. In most cases, the heart valves are affected, but the disease can also occur on septal defects or on the mural endocardium. The disease has been classified as acute or subacute based on the progression of the untreated disease. The acute form has a fulminant course with high fever and leukocytosis with death in less than 6 weeks. It is most often associated with infections caused by Staphylococcus aureus, Streptococcus pneumoniae or Streptococcus pyogenes. The subacute (death within 6 weeks to 3 months) and chronic (death more than 3 months) forms are mostly described together. These forms usually occur in patients with prior valvular disease and are characterized by a slow, indolent course with low-grade fever, night sweats, and weight loss. This form is usually caused by the viridansstreptococci. The above mentioned classification does not include the nonbacterial forms of endocarditis and enterococci often give rise to a disease interrcediate between acute and subacute endocarditis. It is preferable to have a classification based on the micro-organism responsible since this classification has implications for the course followed and the appropriate antimicrobial agent to use. The clinical manifestations of the disease are so varied that they may be encountered in most medical subspecialties. Successful management is also dependent on the close cooperation of medical and dental disciplines.
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00028.x
DO  - doi:10.1111/j.1538-7836.2007.tb00028.x
SP  - P-T-201
EP  - P-T-400
PY  - 2007
ER  - 

TY  - JOUR
AU  - ASTERMARK, J.
AU  - NEGRIER, C.
AU  - HERMANS, C.
AU  - HOLME, P. A.
AU  - KLAMROTH, R.
AU  - KOTSI, P.
AU  - DE MOERLOOSE, P.
AU  - PASI, J.
AU  - ROCINO, A.
AU  - VON DEPKA, M.
AU  - WINDYGA, J.
AU  - LUDLAM, C. A.
AU  - ON BEHALF OF THE INTERDISCIPLINARY WORKING GROUP IDWG
TI  - European curriculum for thrombosis and haemostasis
JO  - Haemophilia
VL  - 15
IS  - 1
SN  - 1351-8216
UR  - https://doi.org/10.1111/j.1365-2516.2008.01836.x
DO  - doi:10.1111/j.1365-2516.2008.01836.x
SP  - 337
EP  - 344
PY  - 2009
ER  - 
